CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Alnylam alumni-led RNAi biotech City Therapeutics files for IPO

IPO/OfferingPositive
AI Analysis

Summary

City Therapeutics, an RNAi biotech founded by Alnylam alumni, submitted its IPO filing. ADARx Pharmaceuticals priced a $446 million Nasdaq debut the same night.

Outcome Details

City Therapeutics submitted IPO filing

Importance:6/10
Sentiment:
0.50
IPORNAiAlnylam alumniKendall Square
Related Companies

Read the original article

Published by Endpoints News on September 25, 2026 11:04 AM

Read Original